Neither APC nor KRAS mutations alone induce a colorectal cancer phenotype [6], although APC mutations also induce RAS activation through inactivation of glycogen synthase kinase 3β (GSK3β) [7]. This evidence concerns the gene KRAS and colorectal cancer.